Lin, Richard J. http://orcid.org/0000-0002-0834-7880
Dahi, Parastoo B.
Korc-Grodzicki, Beatriz
Shahrokni, Armin
Jakubowski, Ann A.
Giralt, Sergio A.
Article History
Accepted: 30 January 2024
First Online: 9 February 2024
Declarations
:
: All authors declare no potential conflicts of interest related to this manuscript.Richard J. Lin is a consultant of Kite Pharmaceuticals and Magenta Pharmaceutics.Parastoo B. Dahi has served on an advisory board for Kite (Gilead).Sergio A. Giralt has served as a consultant for Amgen, Actinium, Celgene, Johnson & Johnson, Jazz Pharmaceutical, Takeda, Novartis, Kite, and Spectrum Pharma and has received research funding from Amgen, Actinium, Celgene, Johnson & Johnson, Miltenyi, and Takeda.
: This article contains no studies with human or animal subjects performed by any of the authors.